Gefion Group Investments A/S made an offer to acquire NeuroSearch A/S (CPSE:NEU) for DKK 97.2 million on April 27, 2018. Under the offer, Neurosearch shareholders will be offered a cash consideration of DKK 4 per share. If the transaction is completed, it will result in an identity change in NeuroSearch, as NeuroSearch's activities after the injection indirectly will consist of the activities in Gefion Group A/S, parent of Gefion Group Investments A/S. The offer will be conditional on Gefion Group Investments obtaining acceptances, or otherwise acquiring shares representing more than 50% of the share capital and voting rights of NeuroSearch, that NeuroSearch's listing is maintained by Nasdaq Copenhagen A/S and that no distribution of any kind is made to the shareholders prior to settlement of the offer. The offer is also conditional upon the annual general meeting on April 30, 2018, not resolving to liquidate NeuroSearch or that NeuroSearchwill be converted into an investment company. The offer period for the offer is expected to commence as soon as possible and no later than four weeks from April 27, 2018, and initially to expire four weeks after publication of the offer document. Jeppe Buskov, Christian Lundgren, Marianne Philip, Thejs Tofting and Agnes Cathrine Emdal Navntoft of Kromann Reumert acted as legal advisor to NeuroSearch A/S.